Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/04/2013 | US8455718 Chimeric regulatory elements for gene expression in leaf mesophyll and bundle sheath cells |
06/04/2013 | US8455717 Collagen producing plants and methods of generating and using same |
06/04/2013 | US8455716 Multiple virus resistance in plants |
06/04/2013 | US8455715 Method for performing homologous recombination in plants |
06/04/2013 | US8455714 DGAT genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
06/04/2013 | US8455713 Plants with improved morphogenesis and method of constructing the same |
06/04/2013 | US8455636 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
06/04/2013 | US8455635 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
06/04/2013 | US8455634 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
06/04/2013 | US8455633 Viral and viral associated mirnas and uses thereof |
06/04/2013 | US8455630 Wood and cell wall gene microarray |
06/04/2013 | US8455629 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
06/04/2013 | US8455628 PP1 ligands |
06/04/2013 | US8455625 Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 |
06/04/2013 | US8455454 miR 204, miR 211, their anti-miRs, and therapeutic uses of same |
06/04/2013 | US8455453 Use of VEGF-D gene to prevent restenosis |
06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
06/04/2013 | US8455248 Cells useful for immuno-based Botulinum toxin serotype A activity assays |
06/04/2013 | US8455247 Cells useful for immuno-based botulinum toxin serotype A activity assays |
06/04/2013 | US8455246 Serum-free mammalian cell culture medium, and uses thereof |
06/04/2013 | US8455244 Co-crystallization of ERR-α with a ligand that forms a reversible covalent bond |
06/04/2013 | US8455243 LRRK2 polynucleotides |
06/04/2013 | US8455239 Yeast organism producing isobutanol at a high yield |
06/04/2013 | US8455236 Compositions and methods of PGL for the increased production of isoprene |
06/04/2013 | US8455233 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
06/04/2013 | US8455232 Overexpression of phytase genes in yeast systems |
06/04/2013 | US8455230 Polynucleotides encoding engineered ketoreductase polypeptides |
06/04/2013 | US8455225 Yeast with increased butanol tolerance involving high osmolarity/glycerol response pathway |
06/04/2013 | US8455224 Enhanced pyruvate to 2,3-butanediol conversion in lactic acid bacteria |
06/04/2013 | US8455223 Dehydrogenases, the derivatives thereof, and method for the production of optically active alkanols |
06/04/2013 | US8455218 Methods for G-CSF production in a Pseudomonas host cell |
06/04/2013 | US8455217 Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof |
06/04/2013 | US8455216 Compositions and methods for reducing H2S levels in fermented beverages |
06/04/2013 | US8455215 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
06/04/2013 | US8455213 Cells useful for immuno-based botulinum toxin serotype A activity assays |
06/04/2013 | US8455199 MicroRNA expression in human peripheral blood microvesicles and uses thereof |
06/04/2013 | US8455195 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
06/04/2013 | US8455187 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria |
06/04/2013 | US8454976 Recombinant toxin fragments |
06/04/2013 | US8454974 Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A |
06/04/2013 | US8454968 Method for inducing immunity with a peptide fragment from human CAPRIN-1 |
06/04/2013 | CA2568844C Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same |
06/04/2013 | CA2551022C Polyethyleneglycol-modified lipid compounds and uses thereof |
06/04/2013 | CA2499926C Antibody against von willebrand factor cleaving enzyme and assay system using the same |
06/04/2013 | CA2474033C Fermentation of pentose sugars |
06/04/2013 | CA2469012C Process of producing glutamate derivatives |
06/04/2013 | CA2448501C Flax (linum usitatissimum l.) seed-specific promoters |
06/04/2013 | CA2432301C Lentiviral vector-mediated gene transfer and uses thereof |
06/04/2013 | CA2405063C Subtilisin variants |
06/04/2013 | CA2228667C Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
05/30/2013 | WO2013078433A1 Auto-processing domains for polypeptide expression |
05/30/2013 | WO2013078316A1 Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides |
05/30/2013 | WO2013078299A1 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
05/30/2013 | WO2013077723A1 Recombinant alpha amylase and the production thereof |
05/30/2013 | WO2013077645A1 Adenovirus producing novel cell line and the use thereof |
05/30/2013 | WO2013077573A1 Hepatitis b virus-derived cis-regulatory element and use thereof |
05/30/2013 | WO2013077563A1 Halocynthia roretzi-derived sialic acid transferase and method for synthesizing sialicated glycoconjugates using same |
05/30/2013 | WO2013077532A1 Novel glutamate decarboxylase variant for salt-free reaction |
05/30/2013 | WO2013077526A1 Preparation method of transgenic asteraceae flowering plant with controlled flower form or flower color, and plant prepared thereby |
05/30/2013 | WO2013077479A1 Method for providing information for diagnosis of breast cancer using real-time reverse transcription polymerase chain reaction, and kit for diagnosis of breast cancer therefor |
05/30/2013 | WO2013077458A1 Anti-human trop-2 antibody exhibiting antitumor activity in vivo |
05/30/2013 | WO2013077446A1 Single-stranded nucleic acid molecule for regulating expression of gene |
05/30/2013 | WO2013077440A1 Plant for producing spirostan-type triterpene |
05/30/2013 | WO2013077432A1 Mutant xylanase, manufacturing method and use therefor, and method for manufacturing saccharified lignocellulose |
05/30/2013 | WO2013077423A1 Method for culturing pluripotent stem cell |
05/30/2013 | WO2013077420A1 Plant transforment, transformation method for plant, and vector used in said method |
05/30/2013 | WO2013077419A1 Gene having function of increasing fruit size for plants, and use thereof |
05/30/2013 | WO2013077332A1 Method for detecting matrix metalloproteinase-3 by latex agglutination method |
05/30/2013 | WO2013077228A1 Impdh inhibitor having microrna as active component |
05/30/2013 | WO2013077186A1 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
05/30/2013 | WO2013076947A1 A method for positively or negatively regulating the assembly of newly synthesized cenp-a to exogenous alphoid dna containing cenp-b boxes in mammalian cell lines |
05/30/2013 | WO2013076730A1 Methods of regulating angiogenesis and compositions capable of same |
05/30/2013 | WO2013076672A1 Plants having enhanced yield-related traits and method for making the same |
05/30/2013 | WO2013076657A1 Map fusion protein |
05/30/2013 | WO2013076650A1 Plants having enhanced yield-related traits and method for making the same |
05/30/2013 | WO2013076374A1 Recombinant serotype 5 (ac!5) adenoviral vectors |
05/30/2013 | WO2013076280A1 Nucleic acid assembly system |
05/30/2013 | WO2013076259A2 Polypeptides having lysozyme activity and polynucleotides encoding same |
05/30/2013 | WO2013076253A1 Polypeptides having lysozyme activity and polynucleotides encoding same |
05/30/2013 | WO2013076167A1 Hla-dr7 hy epitope and method for treating leukemia |
05/30/2013 | WO2013075660A1 Method for highly expressing recombinant protein of engineering bacteria and use thereof |
05/30/2013 | WO2013075644A1 Polypeptides having beta-xylosidase activity and polynucleotides encoding same |
05/30/2013 | WO2013075642A1 Polypeptides having xylanase activity and polynucleotides encoding same |
05/30/2013 | WO2013075630A1 Nano particles of nucleic acid and preparation process and use thereof, and three-head single chain nucleic acid unit |
05/30/2013 | WO2013075608A1 Chimeric recombinant antigen and use thereof |
05/30/2013 | WO2013075553A1 Superantigen fusion protein targeting cancer and preparation method and use thereof |
05/30/2013 | WO2013075244A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery |
05/30/2013 | WO2013075239A1 Diterpene synthases and method for producing diterpenoids |
05/30/2013 | WO2013075237A1 Mutations of histone proteins associated with proliferative disorders |
05/30/2013 | WO2013075233A1 Method for treating brain cancer |
05/30/2013 | WO2013075185A1 Attenuated escherichia coli strains for septicemia in birds, vaccines produced using said strains, method for producing vaccines and uses thereof |
05/30/2013 | WO2013050966A3 Compositions and methods for conferring herbicide resistance |
05/30/2013 | WO2013046034A3 Use of non-subtype b gag proteins for lentiviral packaging |
05/30/2013 | WO2013045934A3 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
05/30/2013 | WO2013040548A3 Fluoride-responsive riboswitchs, fluoride transporters, and methods of use |
05/30/2013 | WO2013038272A3 Streptavidin mutein exhibiting reversible binding for biotin and streptavidin binding peptide tagged proteins |
05/30/2013 | WO2013034982A3 Immunomodulatory peptides for treatment of progressive neurodegenerative diseases |
05/30/2013 | WO2013022320A9 Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof |
05/30/2013 | WO2013022262A3 Human resistin receptor, and use thereof |
05/30/2013 | WO2013022092A9 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |